Cargando…
Combinatorial gene targeting in primary human hematopoietic stem and progenitor cells
The CRISPR/Cas9 system offers enormous versatility for functional genomics but many applications have proven to be challenging in primary human cells compared to cell lines or mouse cells. Here, to establish a paradigm for multiplexed gene editing in primary human cord blood-derived hematopoietic st...
Autores principales: | Bäckström, Alexandra, Yudovich, David, Žemaitis, Kristijonas, Nilsén Falck, Ludvig, Subramaniam, Agatheeswaran, Larsson, Jonas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616885/ https://www.ncbi.nlm.nih.gov/pubmed/36307542 http://dx.doi.org/10.1038/s41598-022-23118-8 |
Ejemplares similares
-
Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells
por: Yudovich, David, et al.
Publicado: (2020) -
Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws
por: Schmiderer, Ludwig, et al.
Publicado: (2020) -
The stem cell–supporting small molecule UM171 triggers Cul3-KBTBD4–mediated degradation of ELM2 domain–harboring proteins
por: Žemaitis, Kristijonas, et al.
Publicado: (2023) -
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
por: Subramaniam, Agatheeswaran, et al.
Publicado: (2022) -
Transient inhibition of NF-κB signaling enhances ex vivo propagation of human hematopoietic stem cells
por: Talkhoncheh, Mehrnaz Safaee, et al.
Publicado: (2018)